IDEXX Q2 FY26 EPS rises 18% to $4.27; revenue increases 10% to USD 1.22 billion

Reuters2026/08/04 10:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

IDEXX Laboratories posted Q2 2026 revenue of $1.22 billion, up 10% year over year; diluted EPS climbed 18% to $4.27.
Operating margin widened 1.4 percentage points to 35%; net income attributable to stockholders rose to $338.41 million.
Companion Animal Group revenue increased 9% to $1.12 billion; Diagnostics recurring revenue rose 11% to $974.71 million.
Water revenue advanced 15% to $58.56 million, while LPD revenue grew 11% to $35.18 million.
Full-year revenue outlook was updated to $4.7 billion-$4.75 billion; EPS forecast lifted to $14.69-$14.94.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260802055382) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

IDEXX Q2 FY26 EPS rises 18% to $4.27; revenue increases 10% to USD 1.22 billion

You may also like

Crypto prices